Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 100.010 | 100.010 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.050 | 20.566 |
Price to Book | 3.215 | 4.169 |
Price to Sales | 2.318 | 2.466 |
Price to Cash Flow | 17.636 | 17.017 |
Dividend Yield | 1.174 | 1.350 |
5 Years Earnings Growth | 15.611 | 13.676 |
Number of long holdings: 62
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 6.01 | 503.25 | -0.61% | |
Eli Lilly | US5324571083 | 4.77 | 794.16 | -0.27% | |
Medincell | FR0004065605 | 4.40 | 16.76 | 0.00% | |
Merck&Co | US58933Y1055 | 3.18 | 99.43 | +0.06% | |
Novartis | CH0012005267 | 2.93 | 87.68 | +1.11% | |
Becton Dickinson | US0758871091 | 2.89 | 226.72 | +0.12% | |
Boston Scientific | US1011371077 | 2.72 | 90.58 | +0.80% | |
UCB | BE0003739530 | 2.21 | 189.40 | -1.17% | |
Thermo Fisher Scientific | US8835561023 | 2.20 | 525.20 | -0.02% | |
Fresenius SE | DE0005785604 | 2.20 | 33.4500 | +0.75% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pluvalca Disruptive Opportunities A | 121.37M | -3.91 | -14.06 | - | ||
Pluvalca France Small Caps A | 92.01M | -4.19 | -4.14 | 5.09 | ||
Pluvalca Initiatives PME A | 70.28M | -11.46 | -9.77 | 7.01 | ||
Pluvalca Allcaps A | 54.69M | -3.22 | 0.52 | 5.61 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review